Ahmed Afifi, Gilead Sciences
Ahmed Afifi, Head of Strategic Planning – Access Operations & Emerging Markets (LatAm – Africa – Asia Pacific), Gilead Sciences
Currently Head of Strategic Planning for the Access Operations & Emerging Markets at Gilead Sciences. My core responsibility is marketing, life cycle management, market access, strategic planning, and portfolio management across all of Gilead’s therapeutic areas in three geographic regions – Latin America, Africa, and Asia Pacific – spanning more than 130 developing and emerging countries. Prior to this role I was the Global Commercial Team Lead at Amgen based in San Francisco and for Novartis in several local, regional and global roles. I am holding a BSc in Pharmacy from Cairo University, and MBA from Academy of Science and Maritime.
Mallika Ann Ambat, Actelion Pharmaceuticals
Mallika Ann Ambat, Senior Director, Market Research, Actelion Pharmaceuticals
Mallika Ann Ambat is the Director, US Market Research Lead at Actelion. She has over twenty years of hands-on pharmaceutical and bio-tech experience.
She started her career at Pharma companies such as Hoffman-La Roche and Schering-Plough on the East Coast, and most recently worked at bio-tech companies, including Agouron-Pfizer (formerly in San Diego) and Actelion in the Bay Area.
She has extensive market research experience with key stakeholders (HCPs, patients and payors) and has worked in both primary care and specialty markets. At Actelion, she works in Pulmonary Arterial Hypertension, MF-CTCL and Gaucher’s Disease.
In her role at Actelion, she collaborates closely with her sales analytic colleagues to optimize decisions for business development, portfolio planning and new product commercialization.
Mallika earned an MBA degree from St. Joseph’s University in Philadelphia and has a B.S. in Life Sciences.
Steve Bell, AplusA Bell Falla
Steve Bell, Senior Partner, AplusA Bell Falla
Steve Bell is a statistician and consultant specializing in pharmaceutical markets and quantitative marketing research methods. Steve has applied his statistical and software development background to create several original quantitative methods tailored to the needs of pharmaceutical marketers. From 1989—1998, Steve was an Assistant Professor of Marketing at the Stern School of Business, New York University. From 2002—2016, together with Juan Falla, Steve was a Founder and Senior Partner of Bell Falla. Since June 2016, Steve has been Senior Partner of AplusA Bell Falla. Steve has a B.A. from Davidson College, M.S. from Texas A&M University, and an MBA and Ph.D. from Columbia University.
Laetitia Bodivit, Lifescience Dynamics
Laetitia Bodivit, M.Sc., Director, Lifescience Dynamics
Laetitia is based in our UK office; she is a marketing professional experienced in both sales and product management. Ex-Bristol-Myers Squibb, she has worked at country and European level and is fluent in English. French is her native language.
She has worked in pharmaceutical and biotechnologies companies on a range of therapeutic areas such as CNS disorders, women’s health, haematology and infectious diseases as well as in in vitro diagnostics.
As an Associate Director, she manages market research, competitive intelligence and market access consulting projects at Lifescience Dynamics.
In her spare time, she likes being outside and hiking with her dog. She also enjoys travelling especially in Asia (China, Hong Kong, Cambodia, Singapore and Bali).
She holds an M.Sc. in Biotechnology from the Ecole de Biologie Industrielle Cergy, France, and a Specialised M.Sc. in Marketing Management for the Pharmaceutical Industry and Biotechnologies from the ESCP Europe Business school, Paris, France.
Meghna Chowdary, Relypsa, Inc.
Meghna Chowdary, Executive Director, Strategic Insights and Analytics, Relypsa, Inc.
Nick Conley, EpiBiome
Nick Conley, CEO & Co-founder, EpiBiome
Dr. Nick Conley is CEO & Co-founder of EpiBiome, a South San Francisco-based venture-backed precision microbiome engineering company whose mission is to surveil microbial populations and to develop the technologies that will protect humanity against the rising global threat of antibiotic resistance.
Dr. Conley completed a Ph.D. in Chemistry and a postdoctoral fellowship in Developmental Biology at Stanford University, where he trained as a synthetic chemist and molecular biologist. He possesses direct Nobel Laureate pedigree, having worked at Stanford University with Prof. W. E. Moerner, winner of the 2014 Nobel Prize in Chemistry. Dr. Conley was a Beckman Fellow, a National Science Foundation Graduate Research Fellow, a Lieberman Fellow, a Stanford Molecular Imaging Scholars Fellow, and a Younger Fellow. He has published 18 peer-reviewed journal articles on topics including palladium catalysis, super-resolution fluorescence imaging, single-molecule DNA detection, and cancer biology, and he holds 4 US patents.
Ryan Cowell, Amgen
Ryan Cowell, Director, Business Analysis & Information, Amgen
Johanna Faigelman, Human Branding, Inc.
Johanna Faigelman, Founding Partner, CEO, Human Branding, Inc.
Johanna Faigelman is the founding partner and CEO of Human Branding Inc., an innovative market research consultancy that has pioneered the use of applied anthropology thinking to create game-changing business results for international clients across a wide range of industries. Johanna has close to 20 years of strategic brand building and customer insight experience, in addition to a graduate and undergraduate degrees in cultural anthropology.
Greg Geddes, Seattle Genetics
Greg Geddes, Director, Market Planning & Analytics, Seattle Genetics
Greg Geddes is Director of Market Planning & Analytics for Seattle Genetics, an oncology therapeutics company. In his role, Greg leads a team responsible for global and US market research, sales forecasting, commercial analysis, and competitive intelligence for Seattle Genetics’ approved product, ADCETRIS, as well as all pipeline products.
Anne Hale, Pfizer
Anne Hale, Business Analytics and Insights NA Lead, Pfizer
Dr. Hale has been with Pfizer’s market analytics group for 10 years. In addition to this role, she also leads the Center of Excellence for HCPs, which is tasked with identifying innovative, efficient research solutions for business issues and decisions relating to our physician customers. She has held several other positions within Pfizer, including the Market Analytics Team Leader for Urology/Respiratory brands, as well as Global Market Analytics Team Leader for New Product Development for a wide range of therapeutic areas.
Prior to joining Pfizer, Anne was a Marketing Professor at both McGill University in Montreal and the University of Victoria in Victoria, British Columbia, Canada, where she taught such courses as Marketing Management, Marketing Research, Business Statistics, Advertising, and Retail Management at both the undergraduate and graduate levels. In addition, she also served a term as Dean of the Undergraduate Program at both McGill University and the University of Victoria, as well as teaching in the Executive Education Institutes of both universities.
Anne holds a Bachelor of Business Administration, Masters of Business Administration and a Doctorate in Marketing, specializing in quantitative methodology, all from the University of Texas at Austin.
Miguel Jimenez, Fast Forward
Miguel Jimenez, Head of Strategy, Fast Forward
Miguel is a Strategic Design Executive specializing in new business innovation, strategic foresight and customer experience design with 15+ years multidisciplinary expertise in technology, social sciences and design.
He is a trusted strategist who helps organizations to discover new business opportunities through a holistic process of observing customers, what they do and why they do it, to apply changes in companies. Driven by customer empathy and deep behavioral analytics Miguel leads teams to use people’s data to ideate, prototype and rollout new product and service offerings with a higher degree of measurable customer desirability.
Miguel has international business and leadership experience in Europe, Asia, North America and South America, and is industry flexible having worked in: design (DesignCouncil Singapore); retail (Zara); banking (Banco Santander, BBVA, Caixa Bank); technology (Terra, Microsoft); telecom (Movistar, Telefonica); real estate (CB Richard Ellis) and media (Yellow Pages).
Jami Krueger, Align Technology
Jami Krueger, Director, Global Insights, Align Technology
Steve Lehrer, Cipla BioTec
Steve Lehrer, CEO, Cipla BioTec
Steven Lehrer is CEO of Cipla BIoTec. Cipla BioTec is “Reinventing Biosimilars” to make cancer treatments affordable worldwide. Steve has over 30 years of experience starting, growing and running life science based businesses focused on commercializing new technology. Steve has extensive experience in pharmaceutical R&D, regulatory and operations, biopharmaceutical R&D, regulatory, operations, commercialization and biosimilars, molecular diagnostics discovery, validation and commercialization, bioinformatics/health care econometrics analysis, health care reimbursement/establishing reimbursement for new medical technology and synthetic biology development and commercialization.
Prior to joing Cipla BioTec, Steve was an EVP Consulting Services at Optimal Strategix Group. Previously he was the EVP of Commercial Operations and CEO of Asia for Adamas Pharmaceuticals, CEO of Geneos, President of Glycominds, CEO of DNA Sciences and a Division President at Monsanto. Prior to his career at Monsanto, Steve worked for McKinsey & Co. and P&G.
Steve currently sits on the Board of Directors of 2 life science companies and provides strategy advise to several CEO/senior management teams on a wide range of topics from commercial strategy through operations /business development and portfolio planning.
Steve has a Master’s Degree from The Graduate School of Business at Harvard University and a BSE in Chemical Engineering and a BA in Economics from the University of Maryland, College Park.
Peggy Lemen, Amgen
Peggy Lemen, Amgen
Michael Luciano, Amgen
Michael Luciano, Sr. Manager, BAI, Amgen
Sales, strategy and marketing professional with over twenty years experience in the BioPharma industry. Diverse therapeutic area exposure with an emphasis in oncology. Award winning sales leader. Highly motivated, team player. Excellent communicator with strong customer interfacing skills.
Keith Lui, Versartis, Inc.
Keith Lui, Vice President, Marketing, Versartis, Inc.
Keith has over 15 years of healthcare experience, with a strong background in several US and global commercial-related areas including new product and medical device development, product and companion diagnostic launches, P&L responsibility, sales & marketing leadership, partnerships, and business development. As the VP of Marketing at Versartis, Inc., he currently leads all US and global market development and commercial planning efforts for somavaratan in multiple orphan indications. Keith joined Versartis from Pharmacylics (now a division of Abbvie), where as VP of Marketing, he led the commercial strategy and execution for the launch of the company’s first new therapy, Imbruvica® (ibrutinib) in multiple hematology/oncology indications. Previously, Keith spent over six years in marketing roles of increasing responsibility at Genentech, Inc., working on oncology teams for Avastin® and Rituxan® and the initial launch of ZELBORAF® and its companion diagnostic. Earlier in his career, he worked in oncology pharmaceutical sales at Johnson & Johnson’s Ortho Biotech and prior to that in healthcare investment banking and genomics research. He earned his MBA, with distinction, from Vanderbilt University, and a BA in Integrative Biology from the University of California at Berkeley.
Steve Martino, M Health
Steve Martino, Co-Managing Partner, M Health
Steve is an award-winning advertising writer and creative director with 30 years of experience in helping marketers recognize opportunities, define strategies and build integrated campaigns in several industries. He began his career at consumer ad agencies working on CPG and automotive accounts. Since 2001 he has been working with global biopharma and healthcare clients. Steve combines a deep understanding of strategy with a highly creative vision.
In 2009 he co-founded M Health, an insight-based brand consultancy focused exclusively on healthcare.
Sarah McNab, Human Branding, Inc.
Sarah McNab, Partner, CSO, Human Branding, Inc.
Sarah McNab is Partner, CSO for Human Branding Inc., an innovative market research consultancy that has pioneered the use of applied anthropology thinking to create game-changing business results for clients across a wide range of industries. Sarah has over 25 years of strategic brand building and customer insight experience from working internationally in a variety of roles in the client, agency and research arenas. With this unique combination of marketing expertise, Sarah provides powerful and enduring brand and customer strategies to leading companies across the globe.
Ram Palanki, Santen Inc.
Ram Palanki, Vice President, Strategic Marketing & Sales, Santen Inc.
Dr. Palanki has more than a decade of experience in ophthalmology across marketing, sales, reimbursement, commercial operations, business development and medical affairs leadership. Ram is currently the Vice President of US Strategic Marketing and Sales for Santen Inc. Prior to joining Santen, he was Global Head of Marketing and Sales at Thrombogenics, Inc. Earlier, he was Director of Global Marketing & Sales at Neovista, Inc. Ram previously worked at Genentech Inc., to develop and launch Lucentis® and subsequent to joining Genentech, he worked at Eyetech Pharmaceuticals as part of the initial team submitting the NDA for Macugen. Ram spent the early days of his career at Novartis Pharmaceuticals, Inc. in the Oncology New Product Commercialization group.
Dr. Palanki completed his postdoctoral fellowship at Rutgers University, and obtained his Pharm.D. from Albany College of Pharmacy, NY.
Neil Patel, Lifescience Dynamics
Neil Patel, Business Analyst, Lifescience Dynamics
Ed Podraza, Allergan
Ed Podraza, Director, Market Research, Allergan
Rafaat Rahmani, Lifescience Dynamics
Rafaat Rahmani, President, Lifescience Dynamics
Rafaat founded Lifescience Dynamics in the summer of 2004. He had a vision of what would make an effective global decision support service, dedicated exclusively to pharmaceutical and biotechnology industries. It would have to be the best in class market research, competitive intelligence and market access, combined with first-rate people and a business model that met their clients’ global insight and foresight requirements. He wanted to deliver a unique service model that hadn’t been available to the market previously, giving pharmaceutical companies a new and interesting way to manage their market, competitors and payer requirements.
Lifescience Dynamics is headquartered in London with offices in New York. They are privileged to boast an extraordinary worldwide customer base, with teams across the globe supporting firms of all sizes, from top 20 pharmaceutical companies through to smaller niche pharma and biotech firms. Lifescience Dynamics has undertaken research across 86 countries.
Prior to founding Lifescience Dynamics, Rafaat was Vice President of a London-based consulting practice where he was responsible for numerous international projects for top 10 pharmaceutical companies, focusing on all aspects of the clinical development and commercialisation environments at US, European and global levels.
Rafaat holds a Bachelor Business Administration from University of Houston, Texas, USA and an MBA from the Manchester Business School, Manchester, UK.
Peter Simpson, Segmedica
Peter Simpson, Principal, Segmedica
Thirty five years of business experience have taken Peter all over the globe. He has lived and worked in the US, UK and Belgium. He has operated in most of the world’s major markets, including Japan and all of Europe. Most of his career has been spent in the Specialty Chemical, Pharmaceutical, Medical Device and Biotechnology areas. His experiences have included the General Management of major businesses, CFO of several companies, Strategic Planning Executive for businesses up to $2.5BN of revenue, as well as acquisitions and divestments, all within the precursor units of AstraZeneca. He is a member of the Royal Institute of Chartered Management Accountants.
He has been Director of Marketing at Life Technologies Inc., a global supplier to the Biotechnology and Biopharmaceutical industry and Vice President of Consulting and Market Research at Lowe Healthcare, one of the world’s largest medical advertising agencies.
His client experience includes AstraZeneca, Schering Plough, Johnson and Johnson, TAP Pharmaceuticals, Boston Scientific, C R Bard, Pfizer, Merck and many more leading companies. He has also worked with HMO’s, Hospitals and Physicians’ Practices.
Peter’s skills include strategic planning processes, branding issues, healthcare marketing and innovative market research. In over a decade of consulting with the healthcare industry he has conducted numerous research projects of all types and is an experienced interviewer and facilitator. He has been researching and developing psychology based methodologies for medical market research for seven years and has developed a number of novel techniques and processes.
Will Simpson, Research Partnership
Will Simpson, Research Manager, Research Partnership
Will is a Research Manager at the Research Partnership. Will has worked for the Research Partnership for four years, during which time he has co-founded the company’s Digital Group, which looks to trial and develop innovative digital and mobile research methodologies in healthcare. Will has a breadth of experience in international healthcare research having worked with both major pharmaceutical companies and medical technology clients, across a range of quantitative, qualitative and mobile research approaches. Will was recently published in Pharma Exec, with an article that explores how researchers can cut through the “noise” and generate practical insights through social media.
Guy Smith, Branding Science
Guy Smith, Vice President, Branding Science
Guy Smith is Vice President of Branding Science US, a full service market research agency that predominantly works in the P2 / P3 space delivering emotional and actionable insights that feed into a brand’s positioning and launch preparations. Guy heads up its West Coast operations where his primary role is overseeing the qualitative and quantitative market research projects led out of the San Francisco office.
John Surie, M Health
John Surie, Customer Insight Director, M Health
John is a strategic brand planner and customer insight specialist with 20 years experience in the development of insight-led international brand positioning and communications concepts. He brings a deeper, more insightful understanding of patient, healthcare provider and payer mind states and attitudes, rooted in an in-depth knowledge of the key global healthcare markets.
In 2009 he co-founded M Health, an insight-based brand consultancy focused exclusively on healthcare.
Scott Tackett, Intuitive Surgical
Scott Tackett, Sr. Director, Global Healthcare Economics, Market Access & Customer Analytics, Intuitive Surgical
Lori Tarabek, Abbott Diabetes Care
Lori Tarabek, Global Market Research Manager, Abbott Diabetes Care
Lori is Senior Manager of Global Market Insights at Abbott Diabetes Care based in Alameda, California. In her current role she is responsible for leading the strategic and foundational market research team.
Lori has had an eclectic market research career in organizations small and large, and in a variety of industries including Consumer Packaged Goods, Healthcare, Diagnostics, Online Services and Medical Devices. She established the primary market research function in three companies and has led teams of primary and secondary market research, business analytics, market and competitive intelligence, demand forecasting and sales administration professionals.
Lori is known for her curious mind, breadth of research expertise and ability to synthesize information into a compelling story yielding strategic business recommendations.
She completed a Bachelor of Arts in Psychological Sciences and a Bachelor of Science in Economics from Purdue University.
Harsh Tiwari, Genentech
Harsh Tiwari, Franchise Lead, Market Analysis & Strategy, Genentech
Harsh Tiwari currently leads the marketing science team for the respiratory franchises at Genentech. Prior to joining Genentech in 2016, Harsh led the market research and portfolio strategy team for two business units at Allergan covering six inline and two pipeline products. He also spent two years at Novartis covering market research and business analytics. Harsh started his career at ZS Associates where led a wide breadth of consulting engagements across commercial sales and marketing strategy and operations, business development, forecasting and managed care strategy.
Harsh’s educational background includes an Executive MBA from Columbia Business School, an MS in Computer Science from Cornell University, and a BS in Computer Engineering from American University Dubai.
Ruchi Varshneya, Abbott
Ruchi Varshneya, Senior Director, Corporate Marketing, Abbott
Ruchi is Senior Director of Global Market Insights and Strategy at Abbott Diabetes Care based in Alameda, California. In her current role she is responsible for driving insights based product innovation and strategic planning. Ruchi has led Insights function and teams in diverse industries including Consumer packaged goods, Application Software, Pharmaceutical and Medical Devices.
She has a reputation of being an authentic voice of the customer. She is regarded as an inspiring and collaborative leader who is respected for setting high goals for her team and consistently delivering on
She earned her engineering degree from India Institute of Technology, India; an MBA from XLRI school of management, India and a Master’s in Public Health from Johns Hopkins University.
Ruchi is passionate about volunteering in her local community and for a variety of causes in India.
Tom Winter, Research Partnership
Tom Winter, Director, Research Partnership
Tom has worked in healthcare market research for the last 14 years. Over this time he has built up experience working with both major pharmaceutical companies and biotech clients. He has developed expertise in research predominantly for pre-launch products, including opportunity assessment, branding research and patient insight mining. He has global experience, conducting research in the US and Europe, as well as emerging markets in Latin America and Asia.
Tom has a MA degree in Genetics from the University of Cambridge, and is a member of the Market Research Society, having been awarded the Advanced Certificate in Social and Market Research.
Denise Woltemath, Health Strategies Group
Denise Woltemath, Vice President/Custom Research, Health Strategies Group
Denise Woltemath is vice president of custom research at Health Strategies Group, where she leads services that maximize the interactions of pharmaceutical and biotechnology companies with physicians and other key providers. Denise led the development of the Oncology Performance Edge service, which advises leading companies on strategies for commercial success. She recently published a groundbreaking assessment on oncology office staff, “The Total Office Call in the Oncology Market.” In the last year, she assessed over 3,500 relationships between oncology representatives and their customers to identify what matters most in developing valuable relationships. She has been a featured speaker at the Society of Pharmaceutical and Biotech Trainers Annual Conference and at the Oncology USA Summit.
Prior to joining Health Strategies Group in 2008, Denise spent more than 10 years at Bristol-Myers Squibb, most recently as the Regional Vice President of Sales. In that position she hired, developed, and motivated over 500 representatives and district managers. Other key accomplishments included developing a training initiative that doubled the length of an average sales call, directing a programmatic approach that extended the impact of promotional education programs, and creating a company-wide framework for opinion leader development. She brings more than 20 years of healthcare experience to the firm, having held leadership roles in pharmaceutical sales, managed care, medical device, and hospital settings.
Lyon Wong, Spectrum 28
Lyon Wong, Co-Founder, Spectrum 28
Lyon Wong is Co-Founder of Spectrum 28, a $170M Silicon Valley VC fund with a focus on industries
undergoing massive change such as Finance, Construction, Real Estate and Genomics. Spectrum 28
has invested in companies such as Karius, Epinomics, Freenome, Vitagene and more. Prior to Spectrum
28, Lyon was an investor at Lightspeed Venture Partners and Meritech Capital. Lyon has invented 30
patents during him time at Microsoft. Lyon received his MBA from Stanford and Engineering degree from
the University of Waterloo. Lyon is a regular speaker/guest at Stanford, Waterloo and a Creative
Destruction Lab Fellow.